APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Transforming Growth Factor-β

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Human Transforming Growth Factor-β Market Analysis and Forecast 2026-2032

Report ID 174031660226 December 2025216 pages

Choose your research edition.

Industry ResearchRecombinant Human Transforming Growth Factor-β Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Transforming Growth Factor-β Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Recombinant Human Transforming Growth Factor-β Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Transforming Growth Factor-β Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Transforming Growth Factor-β Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Recombinant Human Transforming Growth Factor-β market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Human Transforming Growth Factor-β is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Human Transforming Growth Factor-β is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Human Transforming Growth Factor-β is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Human Transforming Growth Factor-β is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Recombinant Human Transforming Growth Factor-β include Abcam, ACROBiosystems, Atlantis Bioscience, Bio-Techne, Cell Guidance Systems, Cell Signaling Technology, Croyez Bioscience, FUJIFILM Irvine Scientific and MedChemExpress, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant Human Transforming Growth Factor-β, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Human Transforming Growth Factor-β, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Human Transforming Growth Factor-β, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Human Transforming Growth Factor-β sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Human Transforming Growth Factor-β market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Human Transforming Growth Factor-β sales, projected growth trends, production technology, application and end-user industry.

Recombinant Human Transforming Growth Factor-β Segment by Company

Abcam

ACROBiosystems

Atlantis Bioscience

Bio-Techne

Cell Guidance Systems

Cell Signaling Technology

Croyez Bioscience

FUJIFILM Irvine Scientific

MedChemExpress

Miltenyi Biotec

Proteintech

Qkine

Sigma-Aldrich

Beijing T&L Biotechnology

Beijing Sino Biological

Dalian Meilun Biotechnology

Cellverse

Nanjing Okay Biotechnology

Thermo Fisher

Shanghai DiLab Biotechnology

Shanghai Zhong Qiao Xin Zhou Biotechnology

Suzhou Novoprotein Scientific

Abbkine Scientific

EIAAB SCIENCE

Yeasen Biotechnology (Shanghai)

Recombinant Human Transforming Growth Factor-β Segment by Type

TGF-β3

TGF-β2

TGF-β1

Recombinant Human Transforming Growth Factor-β Segment by Application

Hospital

Research Institute

Others

Recombinant Human Transforming Growth Factor-β Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Transforming Growth Factor-β market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Transforming Growth Factor-β and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Transforming Growth Factor-β.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Recombinant Human Transforming Growth Factor-β in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Recombinant Human Transforming Growth Factor-β manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Transforming Growth Factor-β sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Human Transforming Growth Factor-β Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. TGF-β3 Major Manufacturers Table 3. TGF-β2 Major Manufacturers Table 4. TGF-β1 Major Manufacturers Table 5. Global Recombinant Human Transforming Growth Factor-β Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Research Institute Major Manufacturers Table 8. Others Major Manufacturers Table 9. Recombinant Human Transforming Growth Factor-β Industry Trends Table 10. Recombinant Human Transforming Growth Factor-β Industry Drivers Table 11. Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges Table 12. Recombinant Human Transforming Growth Factor-β Industry Restraints Table 13. Global Recombinant Human Transforming Growth Factor-β Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021-2026) Table 17. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2027-2032) Table 18. Global Recombinant Human Transforming Growth Factor-β Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2026) & (K Units) Table 20. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2027-2032) & (K Units) Table 21. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021-2026) Table 22. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2027-2032) Table 23. Global Recombinant Human Transforming Growth Factor-β Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Recombinant Human Transforming Growth Factor-β Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers (2021-2026) Table 27. Global Recombinant Human Transforming Growth Factor-β Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Recombinant Human Transforming Growth Factor-β Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Recombinant Human Transforming Growth Factor-β Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Recombinant Human Transforming Growth Factor-β Manufacturers, Product Type & Application Table 31. Global Recombinant Human Transforming Growth Factor-β Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Recombinant Human Transforming Growth Factor-β by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Recombinant Human Transforming Growth Factor-β Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021-2026) Table 38. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2027-2032) Table 39. Global Recombinant Human Transforming Growth Factor-β Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 41. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (K Units) Table 42. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021-2026) Table 43. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2027-2032) Table 44. Global Recombinant Human Transforming Growth Factor-β Price by Type (2021-2026) & (US$/Unit) Table 45. Global Recombinant Human Transforming Growth Factor-β Price by Type (2027-2032) & (US$/Unit) Table 46. Global Recombinant Human Transforming Growth Factor-β Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021-2026) Table 50. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2027-2032) Table 51. Global Recombinant Human Transforming Growth Factor-β Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 53. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (K Units) Table 54. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021-2026) Table 55. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2027-2032) Table 56. Global Recombinant Human Transforming Growth Factor-β Price by Application (2021-2026) & (US$/Unit) Table 57. Global Recombinant Human Transforming Growth Factor-β Price by Application (2027-2032) & (US$/Unit) Table 58. Abcam Company Information Table 59. Abcam Business Overview Table 60. Abcam Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio Table 62. Abcam Recent Development Table 63. ACROBiosystems Company Information Table 64. ACROBiosystems Business Overview Table 65. ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 67. ACROBiosystems Recent Development Table 68. Atlantis Bioscience Company Information Table 69. Atlantis Bioscience Business Overview Table 70. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 72. Atlantis Bioscience Recent Development Table 73. Bio-Techne Company Information Table 74. Bio-Techne Business Overview Table 75. Bio-Techne Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio Table 77. Bio-Techne Recent Development Table 78. Cell Guidance Systems Company Information Table 79. Cell Guidance Systems Business Overview Table 80. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 82. Cell Guidance Systems Recent Development Table 83. Cell Signaling Technology Company Information Table 84. Cell Signaling Technology Business Overview Table 85. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 87. Cell Signaling Technology Recent Development Table 88. Croyez Bioscience Company Information Table 89. Croyez Bioscience Business Overview Table 90. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 92. Croyez Bioscience Recent Development Table 93. FUJIFILM Irvine Scientific Company Information Table 94. FUJIFILM Irvine Scientific Business Overview Table 95. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 97. FUJIFILM Irvine Scientific Recent Development Table 98. MedChemExpress Company Information Table 99. MedChemExpress Business Overview Table 100. MedChemExpress Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio Table 102. MedChemExpress Recent Development Table 103. Miltenyi Biotec Company Information Table 104. Miltenyi Biotec Business Overview Table 105. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio Table 107. Miltenyi Biotec Recent Development Table 108. Proteintech Company Information Table 109. Proteintech Business Overview Table 110. Proteintech Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio Table 112. Proteintech Recent Development Table 113. Qkine Company Information Table 114. Qkine Business Overview Table 115. Qkine Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio Table 117. Qkine Recent Development Table 118. Sigma-Aldrich Company Information Table 119. Sigma-Aldrich Business Overview Table 120. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio Table 122. Sigma-Aldrich Recent Development Table 123. Beijing T&L Biotechnology Company Information Table 124. Beijing T&L Biotechnology Business Overview Table 125. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 127. Beijing T&L Biotechnology Recent Development Table 128. Beijing Sino Biological Company Information Table 129. Beijing Sino Biological Business Overview Table 130. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio Table 132. Beijing Sino Biological Recent Development Table 133. Dalian Meilun Biotechnology Company Information Table 134. Dalian Meilun Biotechnology Business Overview Table 135. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 137. Dalian Meilun Biotechnology Recent Development Table 138. Cellverse Company Information Table 139. Cellverse Business Overview Table 140. Cellverse Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio Table 142. Cellverse Recent Development Table 143. Nanjing Okay Biotechnology Company Information Table 144. Nanjing Okay Biotechnology Business Overview Table 145. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 147. Nanjing Okay Biotechnology Recent Development Table 148. Thermo Fisher Company Information Table 149. Thermo Fisher Business Overview Table 150. Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio Table 152. Thermo Fisher Recent Development Table 153. Shanghai DiLab Biotechnology Company Information Table 154. Shanghai DiLab Biotechnology Business Overview Table 155. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 157. Shanghai DiLab Biotechnology Recent Development Table 158. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information Table 159. Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview Table 160. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 162. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Development Table 163. Suzhou Novoprotein Scientific Company Information Table 164. Suzhou Novoprotein Scientific Business Overview Table 165. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 167. Suzhou Novoprotein Scientific Recent Development Table 168. Abbkine Scientific Company Information Table 169. Abbkine Scientific Business Overview Table 170. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 172. Abbkine Scientific Recent Development Table 173. EIAAB SCIENCE Company Information Table 174. EIAAB SCIENCE Business Overview Table 175. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio Table 177. EIAAB SCIENCE Recent Development Table 178. Yeasen Biotechnology (Shanghai) Company Information Table 179. Yeasen Biotechnology (Shanghai) Business Overview Table 180. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 181. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio Table 182. Yeasen Biotechnology (Shanghai) Recent Development Table 183. North America Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2026) & (US$ Million) Table 184. North America Recombinant Human Transforming Growth Factor-β Revenue by Type (2027-2032) & (US$ Million) Table 185. North America Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 186. North America Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (K Units) Table 187. North America Recombinant Human Transforming Growth Factor-β Sales Price by Type (2021-2026) & (US$/Unit) Table 188. North America Recombinant Human Transforming Growth Factor-β Sales Price by Type (2027-2032) & (US$/Unit) Table 189. North America Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2026) & (US$ Million) Table 190. North America Recombinant Human Transforming Growth Factor-β Revenue by Application (2027-2032) & (US$ Million) Table 191. North America Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 192. North America Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (K Units) Table 193. North America Recombinant Human Transforming Growth Factor-β Sales Price by Application (2021-2026) & (US$/Unit) Table 194. North America Recombinant Human Transforming Growth Factor-β Sales Price by Application (2027-2032) & (US$/Unit) Table 195. North America Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. North America Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. North America Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 200. North America Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 201. North America Recombinant Human Transforming Growth Factor-β Sales Price by Country (2021-2026) & (US$/Unit) Table 202. North America Recombinant Human Transforming Growth Factor-β Sales Price by Country (2027-2032) & (US$/Unit) Table 203. United States Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 204. Canada Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 205. Mexico Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 206. Europe Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2026) & (US$ Million) Table 207. Europe Recombinant Human Transforming Growth Factor-β Revenue by Type (2027-2032) & (US$ Million) Table 208. Europe Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 209. Europe Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (K Units) Table 210. Europe Recombinant Human Transforming Growth Factor-β Sales Price by Type (2021-2026) & (US$/Unit) Table 211. Europe Recombinant Human Transforming Growth Factor-β Sales Price by Type (2027-2032) & (US$/Unit) Table 212. Europe Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2026) & (US$ Million) Table 213. Europe Recombinant Human Transforming Growth Factor-β Revenue by Application (2027-2032) & (US$ Million) Table 214. Europe Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 215. Europe Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (K Units) Table 216. Europe Recombinant Human Transforming Growth Factor-β Sales Price by Application (2021-2026) & (US$/Unit) Table 217. Europe Recombinant Human Transforming Growth Factor-β Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Europe Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Europe Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. Europe Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 222. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 223. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 224. Europe Recombinant Human Transforming Growth Factor-β Sales Price by Country (2021-2026) & (US$/Unit) Table 225. Europe Recombinant Human Transforming Growth Factor-β Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Germany Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 227. France Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 228. U.K. Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 229. Italy Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 230. Russia Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 231. Spain Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 232. Netherlands Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 233. Switzerland Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 234. Sweden Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 235. Poland Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 236. China Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2026) & (US$ Million) Table 237. China Recombinant Human Transforming Growth Factor-β Revenue by Type (2027-2032) & (US$ Million) Table 238. China Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 239. China Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (K Units) Table 240. China Recombinant Human Transforming Growth Factor-β Sales Price by Type (2021-2026) & (US$/Unit) Table 241. China Recombinant Human Transforming Growth Factor-β Sales Price by Type (2027-2032) & (US$/Unit) Table 242. China Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2026) & (US$ Million) Table 243. China Recombinant Human Transforming Growth Factor-β Revenue by Application (2027-2032) & (US$ Million) Table 244. China Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 245. China Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (K Units) Table 246. China Recombinant Human Transforming Growth Factor-β Sales Price by Application (2021-2026) & (US$/Unit) Table 247. China Recombinant Human Transforming Growth Factor-β Sales Price by Application (2027-2032) & (US$/Unit) Table 248. Asia Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2026) & (US$ Million) Table 249. Asia Recombinant Human Transforming Growth Factor-β Revenue by Type (2027-2032) & (US$ Million) Table 250. Asia Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 251. Asia Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (K Units) Table 252. Asia Recombinant Human Transforming Growth Factor-β Sales Price by Type (2021-2026) & (US$/Unit) Table 253. Asia Recombinant Human Transforming Growth Factor-β Sales Price by Type (2027-2032) & (US$/Unit) Table 254. Asia Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2026) & (US$ Million) Table 255. Asia Recombinant Human Transforming Growth Factor-β Revenue by Application (2027-2032) & (US$ Million) Table 256. Asia Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 257. Asia Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (K Units) Table 258. Asia Recombinant Human Transforming Growth Factor-β Sales Price by Application (2021-2026) & (US$/Unit) Table 259. Asia Recombinant Human Transforming Growth Factor-β Sales Price by Application (2027-2032) & (US$/Unit) Table 260. Asia Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 261. Asia Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 262. Asia Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 263. Asia Recombinant Human Transforming Growth Factor-β Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 264. Asia Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 265. Asia Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 266. Asia Recombinant Human Transforming Growth Factor-β Sales Price by Country (2021-2026) & (US$/Unit) Table 267. Asia Recombinant Human Transforming Growth Factor-β Sales Price by Country (2027-2032) & (US$/Unit) Table 268. Japan Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 269. South Korea Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 270. India Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 271. Australia Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 272. Taiwan Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 273. Southeast Asia Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 274. SAMEA Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2026) & (US$ Million) Table 275. SAMEA Recombinant Human Transforming Growth Factor-β Revenue by Type (2027-2032) & (US$ Million) Table 276. SAMEA Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 277. SAMEA Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (K Units) Table 278. SAMEA Recombinant Human Transforming Growth Factor-β Sales Price by Type (2021-2026) & (US$/Unit) Table 279. SAMEA Recombinant Human Transforming Growth Factor-β Sales Price by Type (2027-2032) & (US$/Unit) Table 280. SAMEA Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2026) & (US$ Million) Table 281. SAMEA Recombinant Human Transforming Growth Factor-β Revenue by Application (2027-2032) & (US$ Million) Table 282. SAMEA Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 283. SAMEA Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (K Units) Table 284. SAMEA Recombinant Human Transforming Growth Factor-β Sales Price by Application (2021-2026) & (US$/Unit) Table 285. SAMEA Recombinant Human Transforming Growth Factor-β Sales Price by Application (2027-2032) & (US$/Unit) Table 286. SAMEA Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 287. SAMEA Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 288. SAMEA Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 289. SAMEA Recombinant Human Transforming Growth Factor-β Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 290. SAMEA Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 291. SAMEA Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 292. SAMEA Recombinant Human Transforming Growth Factor-β Sales Price by Country (2021-2026) & (US$/Unit) Table 293. SAMEA Recombinant Human Transforming Growth Factor-β Sales Price by Country (2027-2032) & (US$/Unit) Table 294. Brazil Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 295. Argentina Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 296. Chile Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 297. Colombia Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 298. Peru Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 299. Saudi Arabia Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 300. Israel Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 301. UAE Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 302. Turkey Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 303. Iran Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 304. Egypt Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Table 305. Key Raw Materials Table 306. Raw Materials Key Suppliers Table 307. Recombinant Human Transforming Growth Factor-β Distributors List Table 308. Recombinant Human Transforming Growth Factor-β Customers List Table 309. Research Programs/Design for This Report Table 310. Authors List of This Report Table 311. Secondary Sources Table 312. Primary Sources List of Figures Figure 1. Recombinant Human Transforming Growth Factor-β Image Figure 2. Global Recombinant Human Transforming Growth Factor-β Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Transforming Growth Factor-β Market Size Share 2021 VS 2025 VS 2032 Figure 4. TGF-β3 Image Figure 5. TGF-β2 Image Figure 6. TGF-β1 Image Figure 7. Global Recombinant Human Transforming Growth Factor-β Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Recombinant Human Transforming Growth Factor-β Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Research Institute Image Figure 11. Others Image Figure 12. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Figure 14. Global Recombinant Human Transforming Growth Factor-β Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Recombinant Human Transforming Growth Factor-β Revenu

Scope & coverage.

Types
  • TGF-β3
  • TGF-β2
  • TGF-β1
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • Abcam
  • ACROBiosystems
  • Atlantis Bioscience
  • Bio-Techne
  • Cell Guidance Systems
  • Cell Signaling Technology
  • Croyez Bioscience
  • FUJIFILM Irvine Scientific
  • MedChemExpress
  • Miltenyi Biotec
  • Proteintech
  • Qkine
  • Sigma-Aldrich
  • Beijing T&L Biotechnology
  • Beijing Sino Biological
  • Dalian Meilun Biotechnology
  • Cellverse
  • Nanjing Okay Biotechnology
  • Thermo Fisher
  • Shanghai DiLab Biotechnology
  • Shanghai Zhong Qiao Xin Zhou Biotechnology
  • Suzhou Novoprotein Scientific
  • Abbkine Scientific
  • EIAAB SCIENCE
  • Yeasen Biotechnology (Shanghai)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Human Transforming Growth Factor-β Market by Type
  3. 1.2.1 Global Recombinant Human Transforming Growth Factor-β Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 TGF-β3
  5. 1.2.3 TGF-β2
  6. 1.2.4 TGF-β1
  7. 1.3 Recombinant Human Transforming Growth Factor-β Market by Application
  8. 1.3.1 Global Recombinant Human Transforming Growth Factor-β Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Research Institute
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Recombinant Human Transforming Growth Factor-β Market Dynamics
  1. 2.1 Recombinant Human Transforming Growth Factor-β Industry Trends
  2. 2.2 Recombinant Human Transforming Growth Factor-β Industry Drivers
  3. 2.3 Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Transforming Growth Factor-β Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Recombinant Human Transforming Growth Factor-β Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Region
  3. 3.2.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2021-2026)
  5. 3.2.3 Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2027-2032)
  6. 3.2.4 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Recombinant Human Transforming Growth Factor-β Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Recombinant Human Transforming Growth Factor-β Sales by Region
  9. 3.4.1 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2026)
  11. 3.4.3 Global Recombinant Human Transforming Growth Factor-β Sales by Region (2027-2032)
  12. 3.4.4 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Manufacturers
  2. 4.1.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Recombinant Human Transforming Growth Factor-β Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Human Transforming Growth Factor-β Sales by Manufacturers
  6. 4.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Recombinant Human Transforming Growth Factor-β Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Recombinant Human Transforming Growth Factor-β Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Recombinant Human Transforming Growth Factor-β Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Recombinant Human Transforming Growth Factor-β Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Recombinant Human Transforming Growth Factor-β Manufacturers, Product Type & Application
  13. 4.7 Global Recombinant Human Transforming Growth Factor-β Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Recombinant Human Transforming Growth Factor-β Market CR5 and HHI
  16. 4.8.2 2025 Recombinant Human Transforming Growth Factor-β Tier 1, Tier 2, and Tier 3
5 Recombinant Human Transforming Growth Factor-β Market by Type
  1. 5.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Type
  2. 5.1.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Recombinant Human Transforming Growth Factor-β Sales by Type
  6. 5.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021-2032)
  9. 5.3 Global Recombinant Human Transforming Growth Factor-β Price by Type
6 Recombinant Human Transforming Growth Factor-β Market by Application
  1. 6.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Application
  2. 6.1.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Recombinant Human Transforming Growth Factor-β Sales by Application
  6. 6.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021-2032)
  9. 6.3 Global Recombinant Human Transforming Growth Factor-β Price by Application
7 Company Profiles
  1. 7.1 Abcam
  2. 7.1.1 Abcam Company Information
  3. 7.1.2 Abcam Business Overview
  4. 7.1.3 Abcam Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio
  6. 7.1.5 Abcam Recent Developments
  7. 7.2 ACROBiosystems
  8. 7.2.1 ACROBiosystems Company Information
  9. 7.2.2 ACROBiosystems Business Overview
  10. 7.2.3 ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio
  12. 7.2.5 ACROBiosystems Recent Developments
  13. 7.3 Atlantis Bioscience
  14. 7.3.1 Atlantis Bioscience Company Information
  15. 7.3.2 Atlantis Bioscience Business Overview
  16. 7.3.3 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  18. 7.3.5 Atlantis Bioscience Recent Developments
  19. 7.4 Bio-Techne
  20. 7.4.1 Bio-Techne Company Information
  21. 7.4.2 Bio-Techne Business Overview
  22. 7.4.3 Bio-Techne Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio
  24. 7.4.5 Bio-Techne Recent Developments
  25. 7.5 Cell Guidance Systems
  26. 7.5.1 Cell Guidance Systems Company Information
  27. 7.5.2 Cell Guidance Systems Business Overview
  28. 7.5.3 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio
  30. 7.5.5 Cell Guidance Systems Recent Developments
  31. 7.6 Cell Signaling Technology
  32. 7.6.1 Cell Signaling Technology Company Information
  33. 7.6.2 Cell Signaling Technology Business Overview
  34. 7.6.3 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio
  36. 7.6.5 Cell Signaling Technology Recent Developments
  37. 7.7 Croyez Bioscience
  38. 7.7.1 Croyez Bioscience Company Information
  39. 7.7.2 Croyez Bioscience Business Overview
  40. 7.7.3 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  42. 7.7.5 Croyez Bioscience Recent Developments
  43. 7.8 FUJIFILM Irvine Scientific
  44. 7.8.1 FUJIFILM Irvine Scientific Company Information
  45. 7.8.2 FUJIFILM Irvine Scientific Business Overview
  46. 7.8.3 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  48. 7.8.5 FUJIFILM Irvine Scientific Recent Developments
  49. 7.9 MedChemExpress
  50. 7.9.1 MedChemExpress Company Information
  51. 7.9.2 MedChemExpress Business Overview
  52. 7.9.3 MedChemExpress Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio
  54. 7.9.5 MedChemExpress Recent Developments
  55. 7.10 Miltenyi Biotec
  56. 7.10.1 Miltenyi Biotec Company Information
  57. 7.10.2 Miltenyi Biotec Business Overview
  58. 7.10.3 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio
  60. 7.10.5 Miltenyi Biotec Recent Developments
  61. 7.11 Proteintech
  62. 7.11.1 Proteintech Company Information
  63. 7.11.2 Proteintech Business Overview
  64. 7.11.3 Proteintech Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio
  66. 7.11.5 Proteintech Recent Developments
  67. 7.12 Qkine
  68. 7.12.1 Qkine Company Information
  69. 7.12.2 Qkine Business Overview
  70. 7.12.3 Qkine Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio
  72. 7.12.5 Qkine Recent Developments
  73. 7.13 Sigma-Aldrich
  74. 7.13.1 Sigma-Aldrich Company Information
  75. 7.13.2 Sigma-Aldrich Business Overview
  76. 7.13.3 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio
  78. 7.13.5 Sigma-Aldrich Recent Developments
  79. 7.14 Beijing T&L Biotechnology
  80. 7.14.1 Beijing T&L Biotechnology Company Information
  81. 7.14.2 Beijing T&L Biotechnology Business Overview
  82. 7.14.3 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  84. 7.14.5 Beijing T&L Biotechnology Recent Developments
  85. 7.15 Beijing Sino Biological
  86. 7.15.1 Beijing Sino Biological Company Information
  87. 7.15.2 Beijing Sino Biological Business Overview
  88. 7.15.3 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio
  90. 7.15.5 Beijing Sino Biological Recent Developments
  91. 7.16 Dalian Meilun Biotechnology
  92. 7.16.1 Dalian Meilun Biotechnology Company Information
  93. 7.16.2 Dalian Meilun Biotechnology Business Overview
  94. 7.16.3 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  96. 7.16.5 Dalian Meilun Biotechnology Recent Developments
  97. 7.17 Cellverse
  98. 7.17.1 Cellverse Company Information
  99. 7.17.2 Cellverse Business Overview
  100. 7.17.3 Cellverse Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio
  102. 7.17.5 Cellverse Recent Developments
  103. 7.18 Nanjing Okay Biotechnology
  104. 7.18.1 Nanjing Okay Biotechnology Company Information
  105. 7.18.2 Nanjing Okay Biotechnology Business Overview
  106. 7.18.3 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  108. 7.18.5 Nanjing Okay Biotechnology Recent Developments
  109. 7.19 Thermo Fisher
  110. 7.19.1 Thermo Fisher Company Information
  111. 7.19.2 Thermo Fisher Business Overview
  112. 7.19.3 Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio
  114. 7.19.5 Thermo Fisher Recent Developments
  115. 7.20 Shanghai DiLab Biotechnology
  116. 7.20.1 Shanghai DiLab Biotechnology Company Information
  117. 7.20.2 Shanghai DiLab Biotechnology Business Overview
  118. 7.20.3 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  120. 7.20.5 Shanghai DiLab Biotechnology Recent Developments
  121. 7.21 Shanghai Zhong Qiao Xin Zhou Biotechnology
  122. 7.21.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
  123. 7.21.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
  124. 7.21.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  126. 7.21.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
  127. 7.22 Suzhou Novoprotein Scientific
  128. 7.22.1 Suzhou Novoprotein Scientific Company Information
  129. 7.22.2 Suzhou Novoprotein Scientific Business Overview
  130. 7.22.3 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  132. 7.22.5 Suzhou Novoprotein Scientific Recent Developments
  133. 7.23 Abbkine Scientific
  134. 7.23.1 Abbkine Scientific Company Information
  135. 7.23.2 Abbkine Scientific Business Overview
  136. 7.23.3 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  138. 7.23.5 Abbkine Scientific Recent Developments
  139. 7.24 EIAAB SCIENCE
  140. 7.24.1 EIAAB SCIENCE Company Information
  141. 7.24.2 EIAAB SCIENCE Business Overview
  142. 7.24.3 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio
  144. 7.24.5 EIAAB SCIENCE Recent Developments
  145. 7.25 Yeasen Biotechnology (Shanghai)
  146. 7.25.1 Yeasen Biotechnology (Shanghai) Company Information
  147. 7.25.2 Yeasen Biotechnology (Shanghai) Business Overview
  148. 7.25.3 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio
  150. 7.25.5 Yeasen Biotechnology (Shanghai) Recent Developments
8 North America
  1. 8.1 North America Recombinant Human Transforming Growth Factor-β Market Size by Type
  2. 8.1.1 North America Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2032)
  3. 8.1.2 North America Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032)
  4. 8.1.3 North America Recombinant Human Transforming Growth Factor-β Price by Type (2021-2032)
  5. 8.2 North America Recombinant Human Transforming Growth Factor-β Market Size by Application
  6. 8.2.1 North America Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2032)
  7. 8.2.2 North America Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032)
  8. 8.2.3 North America Recombinant Human Transforming Growth Factor-β Price by Application (2021-2032)
  9. 8.3 North America Recombinant Human Transforming Growth Factor-β Market Size by Country
  10. 8.3.1 North America Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Recombinant Human Transforming Growth Factor-β Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Recombinant Human Transforming Growth Factor-β Market Size by Type
  2. 9.1.1 Europe Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2032)
  3. 9.1.2 Europe Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032)
  4. 9.1.3 Europe Recombinant Human Transforming Growth Factor-β Price by Type (2021-2032)
  5. 9.2 Europe Recombinant Human Transforming Growth Factor-β Market Size by Application
  6. 9.2.1 Europe Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2032)
  7. 9.2.2 Europe Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032)
  8. 9.2.3 Europe Recombinant Human Transforming Growth Factor-β Price by Application (2021-2032)
  9. 9.3 Europe Recombinant Human Transforming Growth Factor-β Market Size by Country
  10. 9.3.1 Europe Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Recombinant Human Transforming Growth Factor-β Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Recombinant Human Transforming Growth Factor-β Market Size by Type
  2. 10.1.1 China Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2032)
  3. 10.1.2 China Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032)
  4. 10.1.3 China Recombinant Human Transforming Growth Factor-β Price by Type (2021-2032)
  5. 10.2 China Recombinant Human Transforming Growth Factor-β Market Size by Application
  6. 10.2.1 China Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2032)
  7. 10.2.2 China Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032)
  8. 10.2.3 China Recombinant Human Transforming Growth Factor-β Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Human Transforming Growth Factor-β Market Size by Type
  2. 11.1.1 Asia Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2032)
  3. 11.1.2 Asia Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032)
  4. 11.1.3 Asia Recombinant Human Transforming Growth Factor-β Price by Type (2021-2032)
  5. 11.2 Asia Recombinant Human Transforming Growth Factor-β Market Size by Application
  6. 11.2.1 Asia Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2032)
  7. 11.2.2 Asia Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032)
  8. 11.2.3 Asia Recombinant Human Transforming Growth Factor-β Price by Application (2021-2032)
  9. 11.3 Asia Recombinant Human Transforming Growth Factor-β Market Size by Country
  10. 11.3.1 Asia Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Recombinant Human Transforming Growth Factor-β Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Recombinant Human Transforming Growth Factor-β Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Human Transforming Growth Factor-β Market Size by Type
  2. 12.1.1 SAMEA Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Recombinant Human Transforming Growth Factor-β Price by Type (2021-2032)
  5. 12.2 SAMEA Recombinant Human Transforming Growth Factor-β Market Size by Application
  6. 12.2.1 SAMEA Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Recombinant Human Transforming Growth Factor-β Price by Application (2021-2032)
  9. 12.3 SAMEA Recombinant Human Transforming Growth Factor-β Market Size by Country
  10. 12.3.1 SAMEA Recombinant Human Transforming Growth Factor-β Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Recombinant Human Transforming Growth Factor-β Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Recombinant Human Transforming Growth Factor-β Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Recombinant Human Transforming Growth Factor-β Value Chain Analysis
  2. 13.1.1 Recombinant Human Transforming Growth Factor-β Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Recombinant Human Transforming Growth Factor-β Production Mode & Process
  6. 13.2 Recombinant Human Transforming Growth Factor-β Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Recombinant Human Transforming Growth Factor-β Distributors
  9. 13.2.3 Recombinant Human Transforming Growth Factor-β Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst